Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

RU58841, a substance from France, can potentially block the effects of hormones that cause hair loss and excessive hair growth, performing better than a similar substance, cyproterone acetate.

Using 2.5 mg/mL triamcinolone acetonide is effective for hair growth in alopecia areata with fewer side effects.

New steroid derivatives show promise as anticancer agents, even against resistant cells.

Multicomponent crystals in microneedles improve drug delivery for hair loss treatment.

Isotretinoin shows promise as a treatment for Chagas disease by effectively inhibiting key transporters in the parasite.

Combining triamcinolone microinjections with minoxidil improves hair growth in women more than minoxidil alone.

Clascoterone is a new, effective, and safe acne treatment without systemic side effects.

Ginsenoside compound K shows promise for treating metabolic diseases like diabetes and obesity.

Isoallopregnanolone may be a safe and effective treatment for reducing tics in a mouse model of Tourette syndrome.

Upadacitinib is effective and safe for treating severe Alopecia Areata in adolescents.

MK-0773 safely increased muscle mass but did not improve muscle strength or function in elderly women with sarcopenia.

The effect of GLP-1 RAs on erectile function is unclear and needs more research.

Opioid use may lower PSA levels, suggesting a possible role in prostate cancer control; PSA testing is useful for detecting prostate cancer; serum triglycerides are not linked to prostate cancer risk; and higher urethral PSA levels may be associated with local hormone activity.

Using a higher concentration of triamcinolone acetonide leads to faster hair regrowth in scalp patchy alopecia areata.

Two new compounds were found to build bone and muscle without affecting reproductive organs and skin oil glands.

Both treatments improved alopecia areata, but methotrexate caused more skin darkening, while triamcinolone caused skin lightening and thinning.

Pentoxifylline alone and combined with triamcinolone acetonide is effective for treating localized alopecia areata, with the combination showing the highest effectiveness.

Certain inhibitors slow down plant growth by causing early cell specialization without changing the cell development pattern.

High-throughput LC-MS screening is effective for finding new autotaxin inhibitors for asthma treatment.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

Blocking CRF1 receptors improved male hormone levels and reduced testicular tumor size in men with a specific adrenal condition.

TRPV3 could be a target for treating pain, skin disorders, and hair problems, but more research is needed to create effective drugs.

Ritlecitinib effectively promotes hair regrowth in severe and very severe alopecia areata.

Targeting the MC-5-HT-HTR2A axis may help treat chronic itching.

The combination therapy was effective and well-tolerated, especially in young patients.

JAK inhibitors effectively treat severe alopecia areata with manageable side effects.

Ritlecitinib is an effective new treatment for Alopecia Areata.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

DS-2325a is safe and well-tolerated, supporting further development for Netherton Syndrome treatment.

Upadacitinib effectively treats severe alopecia areata and is safe.